Antibody‐enhanced hepatitis E virus nanofiltration during the manufacture of human immunoglobulin

BACKGROUND: Circulation of hepatitis E virus (HEV) in areas where plasma is sourced for the manufacture of plasma‐derived medicinal products (PDMPs) has prompted verification of HEV clearance. HEV exists as quasi lipid‐enveloped (LE) and non–lipid‐enveloped (NLE) forms, which might be of relevance f...

Descripción completa

Detalles Bibliográficos
Autores principales: Kapsch, Anna‐Maria, Farcet, Maria R., Wieser, Andreas, Ahmad, Monazza Q., Miyabayashi, Tomoyuki, Baylis, Sally A., Blümel, Johannes, Kreil, Thomas R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754313/
https://www.ncbi.nlm.nih.gov/pubmed/32794187
http://dx.doi.org/10.1111/trf.16014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754313/
https://www.ncbi.nlm.nih.gov/pubmed/32794187
http://dx.doi.org/10.1111/trf.16014

Ejemplares similares